American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1

L. Henderson, S. Canna, K. Friedman, M. Gorelik, S. Lapidus, H. Bassiri, E. Behrens, Anne Ferris, Kate F. Kernan, G. Schulert, P. Seo, Mary Beth F Son, A. Tremoulet, R. Yeung, A. Mudano, Amy S Turner, D. Karp, J. Mehta

Arthritis & rheumatology, 2020

To provide guidance on the management of multisystem inflammatory syndrome in children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan dysfunction that manifests late in the course of severe acute respiratory syndrome coronavirus 2 (SARS–CoV‐2) infection, and to provide recommendations for children with hyperinflammation during coronavirus disease 2019 (COVID‐19), the acute, infectious phase of SARS–CoV‐2 infection.

Cited by 71 publications.

Field of study: Medicine

10.1002/art.41454